Horn Kinney
SEC CIK 1831215 · EDGAR
BoughtSold
Most active insiders at IMNM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barchas Isaac | Dir | — | $18.27M |
| 2 | Rosett Max | CFO | — | $2.52M |
| 3 | Lechleider Robert | Chief Medical Off | — | $2.34M |
| 4 | Horn Kinney | Chief BUSINESS Off | — | $2.30M |
| 5 | SIEGALL CLAY B | Pres, CEO, Dir | $1.75M | — |
| 6 | WAGENHEIM PHILIP | Dir | — | $1.34M |
| 7 | BIENAIME JEAN JACQUES | Dir | $351.4K | $203.8K |
| 8 | Higgins Jack | CSO | — | $538.5K |
| 9 | Tsai Philip | Chief Technical Off | $204.9K | — |
| 10 | Stoneman Sandra G. | CLO, GC | — | — |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-06 18:30 | 2026-08-04 | IMNM | Immunome Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $11.89 | +90.6K | 90.6K | New | +$1.08M |
| DT | 2026-08-06 18:30 | 2026-08-04 | IMNM | Immunome Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $25.09 | -90.6K | 0 | -100% | -$2.27M |
| D | 2026-07-27 16:10 | 2026-07-23 | IMNM | Immunome Inc. | Horn Kinney | Chief BUSINESS Off | A - Grant | $0.00 | +31.2K | 31.2K | New | $0 |
| DT | 2026-07-09 17:38 | 2026-07-07 | IMNM | Immunome Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $12.92 | +1,092 | 1,092 | New | +$14.1K |
| DT | 2026-07-09 17:38 | 2026-07-07 | IMNM | Immunome Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $25.00 | -1,092 | 0 | -100% | -$27.3K |
| D | 2022-03-14 | 2022-03-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,253 | 7,711 | +214% | +$10.8K |
| D | 2022-03-14 | 2022-03-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $4.75 | -5,253 | 2,458 | -68% | -$25.0K |
| D | 2022-02-14 | 2022-02-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,709 | +214% | +$10.8K |
| D | 2022-02-14 | 2022-02-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | D - Sale to Iss | — | -5,251 | 2,458 | -68% | — |
| D | 2022-01-11 | 2022-01-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,709 | +214% | +$10.8K |
| D | 2022-01-11 | 2022-01-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $6.85 | -5,251 | 2,458 | -68% | -$36.0K |
| D | 2021-12-14 | 2021-12-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,709 | +214% | +$10.8K |
| D | 2021-12-14 | 2021-12-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $10.39 | -5,251 | 2,458 | -68% | -$54.6K |
| DM | 2021-11-12 | 2021-11-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $15.79 | +27.7K | 29.5K | +1,546% | +$436.7K |
| D | 2021-11-12 | 2021-11-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $26.88 | -27.7K | 1,790 | -94% | -$743.7K |
| DM | 2021-10-12 | 2021-10-11 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $27.90 | -5,251 | 4,936 | -52% | -$146.5K |
| D | 2021-10-12 | 2021-10-11 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,041 | +293% | +$10.8K |
| D | 2021-09-13 | 2021-09-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $29.38 | -5,251 | 1,790 | -75% | -$154.3K |
| D | 2021-09-13 | 2021-09-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,041 | +293% | +$10.8K |
| D | 2021-08-11 | 2021-08-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,041 | +293% | +$10.8K |
| DM | 2021-08-11 | 2021-08-10 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $25.71 | -5,251 | 1,850 | -74% | -$135.0K |
| D | 2021-07-13 | 2021-07-12 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,041 | +293% | +$10.8K |
| DM | 2021-07-13 | 2021-07-12 | OLMA | Olema Pharmaceuticals, Inc. | Horn Kinney | Chief BUSINESS Off | S - Sale+OE | $26.51 | -5,251 | 3,182 | -62% | -$139.2K |
Purchase Sale Sale after option exercise All abbreviations